Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Logothetis

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Histopathology|June 29, 2011
Expression of hedgehog pathway components in prostate carcinoma microenvironment: shifting the balance towards autocrine signallingVassiliki Tzelepi, Maria Karlou, Sijin Wen, et al.
Prostate Cancer and Prostatic Diseases|October 8, 2020
Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancerArif Hussain, Abhishek Tripathi, Christopher Pieczonka, et al.
The Journal of Biological Chemistry|July 18, 2002
Inhibition of prostate tumor angiogenesis by the tumor suppressor CEACAM1Olga Volpert, Weiping Luo, Ta-Jen Liu, et al.
Cancers|September 9, 2023
Lineage Plasticity and Stemness Phenotypes in Prostate Cancer: Harnessing the Power of Integrated "Omics" Approaches to Explore Measurable MetricsSouzana Logotheti, Eugenia Papadaki, Vasiliki Zolota, et al.
Cancer Letters|January 16, 2002
Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207Artur Plonowski, Andrew V Schally, Attila Nagy, et al.
Journal of the National Medical Association|December 30, 2004
Prognostic factors for survival among Caucasian, African-American and Hispanic men with androgen-independent prostate cancerReena B Wyatt, Ricardo F Sánchez-Ortiz, Christopher G Wood, et al.
The Journal of Urology|November 11, 2005
Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancerDan Leibovici, Ashish M Kamat, Curtis A Pettaway, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2008
CTLA-4 blockade increases IFNgamma-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patientsChrysoula I Liakou, Ashish Kamat, Derek Ng Tang, et al.
Cell & Bioscience|October 14, 2014
Posttranslational regulation of Akt in human cancerChia-Hsin Chan, Ukhyun Jo, Abraham Kohrman, et al.
BMC Genomics|March 25, 2014
How to get the most from microarray data: advice from reverse genomicsIvan P Gorlov, Ji-Yeon Yang, Jinyoung Byun, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Histopathology|June 29, 2011
Expression of hedgehog pathway components in prostate carcinoma microenvironment: shifting the balance towards autocrine signallingVassiliki Tzelepi, Maria Karlou, Sijin Wen, et al.
Prostate Cancer and Prostatic Diseases|October 8, 2020
Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancerArif Hussain, Abhishek Tripathi, Christopher Pieczonka, et al.
The Journal of Biological Chemistry|July 18, 2002
Inhibition of prostate tumor angiogenesis by the tumor suppressor CEACAM1Olga Volpert, Weiping Luo, Ta-Jen Liu, et al.
Cancers|September 9, 2023
Lineage Plasticity and Stemness Phenotypes in Prostate Cancer: Harnessing the Power of Integrated "Omics" Approaches to Explore Measurable MetricsSouzana Logotheti, Eugenia Papadaki, Vasiliki Zolota, et al.
Cancer Letters|January 16, 2002
Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207Artur Plonowski, Andrew V Schally, Attila Nagy, et al.
Journal of the National Medical Association|December 30, 2004
Prognostic factors for survival among Caucasian, African-American and Hispanic men with androgen-independent prostate cancerReena B Wyatt, Ricardo F Sánchez-Ortiz, Christopher G Wood, et al.
The Journal of Urology|November 11, 2005
Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancerDan Leibovici, Ashish M Kamat, Curtis A Pettaway, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2008
CTLA-4 blockade increases IFNgamma-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patientsChrysoula I Liakou, Ashish Kamat, Derek Ng Tang, et al.
Cell & Bioscience|October 14, 2014
Posttranslational regulation of Akt in human cancerChia-Hsin Chan, Ukhyun Jo, Abraham Kohrman, et al.
BMC Genomics|March 25, 2014
How to get the most from microarray data: advice from reverse genomicsIvan P Gorlov, Ji-Yeon Yang, Jinyoung Byun, et al.
Pageof 9